source
- Gene therapy sponsors urged to address six GMP manufacturing considerations earlySK pharmteco’s chief technical officer Tatiana Nanda explained that gene therapy sponsors need to think about manufacturing issues well before reaching GMP production. She told BioSpace that early…
- Trump administration issues new guidelines to curb AI-driven bioweapon threatsThe White House announced a set of guidelines aimed at preventing the misuse of artificial intelligence in creating biological weapons. Officials said the rapid advances in AI-driven drug discovery…